News & Insights
The latest from Hill Research on AI in clinical trials, biostatistics innovation, and industry developments.
Louise Liu Named to 2026 Top 10 Outstanding Chinese American Youth
Hill Research CEO Dr. Louise Liu has been named one of the 2026 Top 10 Outstanding Chinese American Youth by the American Chinese Youth Federation (AACYF), recognized in the Technology and Academia category for building an AI-powered clinical data platform that compresses processes traditionally requiring months into approximately 90 minutes.
Hill Research Co-Hosts Clinical AI Mastermind S1 at J&J Innovative Medicine
Hill Research co-hosted Session 1 of the Clinical AI Mastermind 2026 series — 'The Submission Last-Mile: Redefining Clinical Velocity' — at Johnson & Johnson Innovative Medicine in Cambridge, with Director-plus leaders from Pfizer, J&J, Takeda, and Alexion.
Louise Liu Joins Antiverse's The Future of Drug Discovery Podcast
Hill Research CEO Dr. Louise Liu joins Antiverse founder Murat Tunaboylu on The Future of Drug Discovery podcast to discuss how Hill Research compresses an FDA submission data package — typically eight programmers, six months, and eight million dollars — down to one person in 90 minutes using generative AI.
Hill Research at the Bay Area Biotech-Pharma Statistics Workshop (BBSW)
The Hill Research team is at the Bay Area Biotech-Pharma Statistics Workshop (BBSW), connecting with biostatisticians and clinical teams on Phase II/III trial design, statistical analysis, and FDA-registration support.
Hill Research's Tom Chen to Present Med-ICE at MBSW 2026
Hill Research's Tom (Zhiyuan) Chen will present Med-ICE — a multi-agent consensus framework for medical AI factual accuracy — at the 49th Annual Midwest Biopharmaceutical Statistics Workshop (MBSW) in Carmel, Indiana, May 27–29, 2026.
Louise Liu Joins AI Panel at BioNJ BioPartnering Conference
Hill Research CEO Dr. Louise Liu joined the panel 'From Algorithm to Impact — Deploying AI in Real-World Life Sciences' at the BioNJ BioPartnering Conference, discussing what it takes to move AI beyond theory into real-world clinical, operational, and commercial impact.
Hill Research Partners with ZenQMS for Enterprise eQMS
Hill Research is partnering with ZenQMS to run its enterprise electronic quality management system — bringing 21 CFR Part 11 and ISO 27001-compliant document control, training, change control, and audit management to the organization that operates TriClick.
Hill Research Showcases at NJEDA Innovation Evergreen Fund Board Advisory Meeting
Hill Research had the opportunity to showcase its AI infrastructure for clinical trial biometrics at the NJEDA NJ Innovation Evergreen Fund Board Advisory Meeting, joining founders, investors, researchers, and public leaders advancing healthcare and AI innovation in New Jersey.
Hill Research Named to 2026 Innovate100 in New Jersey
Hill Research has been named to the 2026 Innovate100, recognizing New Jersey's top innovation leaders. CEO Dr. Louise Liu is honored in the Life Sciences category alongside leaders from J&J, BMS, Sanofi, Bayer, Rutgers, and Princeton.
Louise Liu Named 2026 Rising Star Entrepreneur by The Serica Initiative
Hill Research CEO Dr. Louise Liu has been named the 2026 Rising Star in Entrepreneurship by The Serica Initiative, recognizing emerging AAPI women leaders shaping the future across entrepreneurship, corporate, and nonprofit sectors.
Five Papers Accepted at ACL, SIGMETRICS, MLSys, and JAMIA in One Week
Hill Research's CTO Dr. Jack Li had four papers accepted at top computer science venues — two at ACL 2026, one at SIGMETRICS 2026, and one at MLSys 2026 — plus a peer-reviewed publication in JAMIA Open describing ClinicalMind, the knowledge graph layer underneath TriClick.
Podcast: Building Trust in Medical AI — Inside Med-ICE
In this episode of AI on the Hill in the Spotlight, Zhiyuan Chen discusses Med-ICE, a multi-agent consensus framework designed to improve the trustworthiness and reliability of medical AI by aligning reasoning across multiple LLM agents.
Hill Research Presents at AAAI 2026 SPARTA Workshop in Singapore
Hill Research's AI team presented three research projects at the SPARTA workshop during AAAI 2026, covering cross-species transfer learning, dynamic gene expression modeling, and reducing LLM hallucinations in clinical AI.
Webinar: FDA Perspectives on AI in Biometrics — Key Pitfalls, Bias Risks, and What Sponsors Must Get Right
This AI on the Hill webinar brings together FDA, biostatistics, and legal experts to examine how AI is evaluated in biometrics today, focusing on practical FDA-facing realities, sponsor mistakes, and accountability requirements.
Hill Research Releases TriClick™ Product Video During JPM Week 2026
Hill Research unveils a product video during JPM Week 2026 introducing TriClick™, the first-in-class agentic AI system designed to generate submission-ready TFLs from raw clinical datasets in 90 minutes.
Managing Biometrics in 2026: What Every Biostats Leader Must Know About AI
Hill Research and AI on the Hill launch 2026 with a live panel discussion bringing together leaders from regulatory, biostatistics, legal, and AI-driven CRO communities to examine how AI is transforming biometrics workflows.
Signal Night: Healthcare AI @ JPM 2026
Hill Research co-hosts Signal Night, an invite-only late-night gathering during JPM Week for founders, investors, and healthcare leaders building and funding AI solutions that are already shipping.
Hill Research Named Finalist at the 2025 Eddies Innovation Showcase
Hill Research is selected as a finalist at the 2025 Eddies Innovation Showcase, hosted by the Mass Innovation Network, presenting its flagship AI platform TriClick™.
Louise Liu Named to Boston Business Journal's Prestigious 2025 "40 Under 40" List
Hill Research CEO Louise Liu, PhD, MBA is recognized among the Boston Business Journal's 2025 '40 Under 40' honorees for her work in AI, biostatistics, and healthcare innovation.
Hill Research CEO Dr. Louise Ruihua Liu Honored as International Business Leader at Witherspoon Gala 2025
Dr. Louise Ruihua Liu receives the International Business Leader Award at the Witherspoon Gala 2025 for her pioneering leadership in AI-driven biostatistics and clinical trial innovation.
Ten Minutes. Thirty-Six Errors. One Big Win: Hill Research at the AI Frontier
At a Boston roundtable, Hill Research CEO Dr. Louise Liu shares how the company's AI platform identified 36 critical errors in a competitor's report within ten minutes, securing a new client relationship.
Hill Research New Preprint: AI-Powered Framework for Cross-Species Single-Cell Insight
Hill Research announces a new preprint on BioRxiv introducing CSLAN, a transfer learning framework that uses mouse scRNA-seq data to identify human trauma-related immune cells with 96.67% accuracy.